OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · IEX Real-Time Price · USD
10.14
-0.25 (-2.36%)
Jun 25, 2024, 3:19 PM EDT - Market open

OptimizeRx Revenue

OptimizeRx had revenue of $78.21M in the twelve months ending March 31, 2024, with 26.71% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $19.69M with 51.43% year-over-year growth. In the year 2023, OptimizeRx had annual revenue of $71.52M with 14.53% growth.

Revenue (ttm)
$78.21M
Revenue Growth
+26.71%
P/S Ratio
2.42
Revenue / Employee
$579,323
Employees
135
Market Cap
186.17M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202371.52M9.07M14.53%
Dec 31, 202262.45M1.16M1.89%
Dec 31, 202161.29M17.98M41.51%
Dec 31, 202043.31M18.72M76.08%
Dec 31, 201924.60M3.39M15.99%
Dec 31, 201821.21M9.08M74.86%
Dec 31, 201712.13M4.38M56.45%
Dec 31, 20167.75M530.78K7.35%
Dec 31, 20157.22M717.72K11.04%
Dec 31, 20146.50M1.82M38.96%
Dec 31, 20134.68M2.69M135.27%
Dec 31, 20121.99M877.57K78.95%
Dec 31, 20111.11M1.04M1,464.09%
Dec 31, 201071.07K44.34K165.93%
Dec 31, 200926.72K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 321.52M
Coherus BioSciences 301.87M
2seventy bio 71.20M
NeuroPace 69.07M
Butterfly Network 68.08M
EDAP TMS 65.80M
Biodesix 54.85M
Genfit 42.42M
Revenue Rankings